Rao, Yu

Chemistries of bifunctional PROTAC degraders

Cao, C., He, M., Wang, L., He, Y., & Rao, Y. (2022) · Chemical Society Reviews

Protein Degradation and InhibitorsChemical Synthesis and Analysis

Cited by 313

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies

Sun, Y., Zhao, X., Ding, N., Gao, H., Wu, Y., Yang, Y., Zhao, M., Hwang, J., Song, Y., Liu, W., et al. (2018) · Cell Research

Protein Degradation and InhibitorsChronic Lymphocytic Leukemia Research

Cited by 295

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 283

Degradation of Bruton’s tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas

Sun, Y., Ding, N., Song, Y., Yang, Z., Liu, W., Zhu, J., & Rao, Y. (2019) · Leukemia

Protein Degradation and InhibitorsChronic Lymphocytic Leukemia Research

Cited by 148

Developing potent PROTACs tools for selective degradation of HDAC6 protein

An, Z., Lv, W., Su, S., Wu, W., & Rao, Y. (2019) · Protein & Cell

Protein Degradation and InhibitorsHistone Deacetylase Inhibitors Research

Cited by 133

A chemical approach for global protein knockdown from mice to non-human primates

Sun, X., Wang, J., Yao, X., Zheng, W., Mao, Y., Lan, T., Wang, L., Sun, Y., Zhang, X., Zhao, Q., et al. (2019) · Cell Discovery

Protein Degradation and InhibitorsChemical Synthesis and Analysis

Cited by 118

Plasticity in designing PROTACs for selective and potent degradation of HDAC6

Yang, H., Lv, W., He, M., Deng, H., Li, H., Wu, W., & Rao, Y. (2019) · Chemical Communications

Protein Degradation and InhibitorsHistone Deacetylase Inhibitors Research

Cited by 108